Skip to main content

Blood Biomarker-based Diagnostic Tools for Early Stage Alzheimer’s Disease

Ziel

Alzheimer’s disease (AD) affects more than 7 million people in Europe and this figure is expected to double every 20 years. Despite intensive efforts, no disease-modifying treatments or preventive strategies are available. The lack of specific, sensitive and minimally invasive diagnostics to identify people with early-stage AD to be included in clinical drug intervention trials is among the main reasons for many notable trial failures. The main challenges in developing the required diagnostics are identification of AD biomarkers and development of their detection techniques. The complex and interdisciplinary nature of the research underlines the need for innovative training of a new generation of researchers in the field. BBDiag responds to such a need and establishes a much-needed ETN for blood based early-AD diagnostics to address these challenges. It brings together leading academic and industrial experts from five major consortia in Europe and uses their synergies to build a triple-i research & training platform with the required multidisciplinary expertise and cutting-edge technologies. BBDiag Fellows will be trained under the Vitae Researcher Development Framework innovatively combined with the BBDiag platform for gaining interdisciplinary scientific and transferable skills as well as personal quality, creative thinking and business mind-set. The ETN has a highly innovative research programme for the discovery of AD biomarkers, development of novel biosensing techniques and point of care tools, and for technological exploitation of the diagnostics. These advances will strongly support improved care provision and development of disease-modifying treatments and preventive strategies for AD patients. More importantly, BBDiag will deliver its first generation of 13 highly-skilled, creative and entrepreneurial Fellows, setting them on a path to successful careers in academia or industry to ensure that the medical and societal challenges imposed by AD are met.

Wissenschaftliches Gebiet

  • /Sozialwissenschaften/Wirtschaftswissenschaften
  • /Technik und Technologie/Umweltbiotechnologie/Biosensorik
  • /Medizin- und Gesundheitswissenschaften/Grundlagenmedizin/Neurologie/Alzheimer

Aufforderung zur Vorschlagseinreichung

H2020-MSCA-ITN-2016
Andere Projekte für diesen Aufruf anzeigen

Finanzierungsplan

MSCA-ITN-ETN - European Training Networks

Koordinator

UNIVERSITY OF PLYMOUTH
Adresse
Drake Circus
PL4 8AA Plymouth
United Kingdom
Aktivitätstyp
Higher or Secondary Education Establishments
EU-Beitrag
€ 819 863,64

Beteiligte (10)

DANMARKS TEKNISKE UNIVERSITET
Dänemark
EU-Beitrag
€ 290 081,88
Adresse
Anker Engelundsvej 1 Bygning 101 A
2800 Kgs Lyngby
Aktivitätstyp
Higher or Secondary Education Establishments
NORDIC BIOSCIENCE A/S
Dänemark
EU-Beitrag
€ 290 081,88
Adresse
Herlev Hovedgade 205-207
2730 Herlev
Aktivitätstyp
Private for-profit entities (excluding Higher or Secondary Education Establishments)
NORDIC BIOSCIENCE COMPOUND DEVELOPMENT A/S

Beteiligung beendet

Dänemark
EU-Beitrag
€ 0
Adresse
Herlev Hovedgade 207
2730 Helev
Aktivitätstyp
Private for-profit entities (excluding Higher or Secondary Education Establishments)
ISTITUTO DI RICERCHE FARMACOLOGICHE MARIO NEGRI
Italien
EU-Beitrag
€ 424 439,19
Adresse
Via Mario Negri 2
20156 Milano
Aktivitätstyp
Research Organisations
PROGNOMICS LTD
United Kingdom
EU-Beitrag
€ 273 287,88
Adresse
Broomfield & Alexander Ltd Charter Court Phoenix Way Enterprise Park
SA7 9FS Swansea
Aktivitätstyp
Private for-profit entities (excluding Higher or Secondary Education Establishments)
SWANSEA UNIVERSITY
United Kingdom
EU-Beitrag
€ 273 287,88
Adresse
Singleton Park
SA2 8PP Swansea
Aktivitätstyp
Higher or Secondary Education Establishments
UNIVERSITA DEGLI STUDI DI ROMA LA SAPIENZA
Italien
EU-Beitrag
€ 516 122,64
Adresse
Piazzale Aldo Moro 5
00185 Roma
Aktivitätstyp
Higher or Secondary Education Establishments
CENTRO DE INVESTIGACION BIOMEDICA EN RED ENFERMEDADES NEURODEGENERATIVAS
Spanien
EU-Beitrag
€ 247 872,96
Adresse
"Hospital Universitario ""Virgen Del Rocio"" - Edif. De Laboratorios, 2A Planta - Avda. Manual Siurot S/n"
41013 Sevilla
Aktivitätstyp
Research Organisations
UNIVERSITATSMEDIZIN ROSTOCK
Deutschland
EU-Beitrag
€ 249 216,48
Adresse
Schillingallee 35
18055 Rostock
Aktivitätstyp
Higher or Secondary Education Establishments
ADVANCED MEDICAL PROJECTS SOCIEDAD LIMITADA

Beteiligung beendet

Spanien
EU-Beitrag
€ 81 453,81
Adresse
Avda Chiloeches Num 73
19160 Guadalajara
Aktivitätstyp
Private for-profit entities (excluding Higher or Secondary Education Establishments)

Partner (4)

HUNAN UNIVERSITY
China
Adresse
Lushan South Road 1
410082 Changsha
Aktivitätstyp
Higher or Secondary Education Establishments
China Capital Medical University
China
Adresse
Xi Tou Tiao, You An Men Wai 10
100069 Beijing
Aktivitätstyp
Higher or Secondary Education Establishments
ENGAGE - KEY TECHNOLOGY VENTURES AG
Deutschland
Adresse
Bahnhofstrasse 54
76137 Karlsruhe
Aktivitätstyp
Private for-profit entities (excluding Higher or Secondary Education Establishments)
Re:Cognition Health Ltd.
United Kingdom
Adresse
45 Queen Anne Street
W1G 9JF London
Aktivitätstyp
Private for-profit entities (excluding Higher or Secondary Education Establishments)